NeurologyLive® Friday 5 — March 25, 2022

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 25, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Unraveling the Complexities of Cerebral Palsy and Building Hope for a Brighter Future

During Cerebral Palsy Awareness Month, leaders in the field, including Elizabeth Barkoudah, MD; Bhooma Aravamuthan, MD, DPhil; and Danielle Guez Barber, MD, PhD, expressed their love for the CP community, the progress made in managing the disorders, and the steps needed to advance care into a realm never before seen.

2: NeuroVoices: Jefferson Kinney, PhD, on Building a Sustainable Neuroscience Research Infrastructure

The founding chair of the department of brain health at UNLV discussed a recently awarded NIH grant dedicated to advancing neuroscience research for the long-term future, and provided commentary on new key components to phase 2, and why biomarkers will be a major topic of discussion going forward.

3: Mind Moments Episode 60: Improving Care and Raising Awareness for NMOSD

Mind Moments, a podcast from NeurologyLive®, brings you an exclusive interview with Friedmann Paul, MD, about the state of research for NMOSD, the therapeutic landscape and future, and other hot topics during the disorder's awareness month.

4: Peers & Perspectives: Overview of OFF Episodes in Parkinson Disease

In Episode 1 of this NeurologyLive® Peers & Perspectives series, "Practical Considerations in the Management of OFF-Episodes in Parkinson Disease," Laxman Bahroo, DO, and Sanjay Iyer, MD, define OFF episodes in Parkinson disease and review motor and nonmotor symptoms in patients.

5: Improving and Expanding Access to ALS Treatment Options: Calaneet Balas, MSc

The president and chief executive officer of The ALS Association provided commentary on the most pertinent issues with managing patients with ALS and the ways to improve current treatment standards.

—————————————————